Want to see HK:1612 full AI Analyst Report?
Top Page
Vincent Medical Holdings Limited
(1612)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$0.77
▼(-7.83% Downside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by a recovering financial profile (improving margins and ROE) but moderated by uneven cash-flow consistency and historical volatility. Valuation is a major positive with a very low P/E and high dividend yield, while technicals are the main offset due to a clear downtrend and weak momentum.
Positive Factors
Revenue Reacceleration
Several consecutive years of revenue growth indicate recovering demand and broader product adoption. Continued expansion would support operating leverage and provide a durable base for future earnings, although the pace has moderated.
Negative Factors
Inconsistent Cash Conversion
Weak and uneven conversion of earnings into cash reduces the quality of reported profitability. It may constrain internally funded investment, dividends, or debt reduction if working capital or operating needs absorb cash again.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Reacceleration
Several consecutive years of revenue growth indicate recovering demand and broader product adoption. Continued expansion would support operating leverage and provide a durable base for future earnings, although the pace has moderated.
Read all positive factors
Vincent Medical Holdings Limited (1612) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$442.27M
Dividend Yield6.87%
Average Volume (3M)277.67K
Price to Earnings (P/E)4.5
Beta (1Y)0.67
Revenue Growth10.95%
EPS Growth9.26%
CountryHK
Employees1,556
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.15
Shares Outstanding660,098,800
10 Day Avg. Volume425,200
30 Day Avg. Volume277,666
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.81
Price to Sales (P/S)0.57
P/FCF Ratio9.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.12
Revenue Forecast (FY)HK$1.17B
Vincent Medical Holdings Limited Business Overview & Revenue Model
Company Description
Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing...
How the Company Makes Money
Vincent Medical Holdings Limited primarily makes money by selling medical devices and related consumables to healthcare providers and distribution channels. Revenue is generated from (i) sales of respiratory care products (typically used in hospit...
Vincent Medical Holdings Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
71
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 964.90M | 932.78M | 800.96M | 717.97M | 629.24M | 777.72M |
| Gross Profit | 333.74M | 327.44M | 259.99M | 240.39M | 147.83M | 243.83M |
| EBITDA | 155.83M | 155.33M | 100.00M | 104.43M | 29.95M | 114.55M |
| Net Income | 96.30M | 104.38M | 69.17M | 57.27M | -17.40M | 60.70M |
Balance Sheet | ||||||
| Total Assets | 1.27B | 1.17B | 919.68M | 786.61M | 726.70M | 846.15M |
| Cash, Cash Equivalents and Short-Term Investments | 199.93M | 250.87M | 173.44M | 175.78M | 159.34M | 173.17M |
| Total Debt | 240.66M | 177.42M | 99.65M | 37.38M | 60.39M | 62.96M |
| Total Liabilities | 546.08M | 498.33M | 336.33M | 243.52M | 228.09M | 245.72M |
| Stockholders Equity | 715.77M | 664.65M | 578.55M | 541.84M | 498.01M | 598.36M |
Cash Flow | ||||||
| Free Cash Flow | 68.70M | 54.64M | -26.52M | 61.28M | 57.67M | 94.48M |
| Operating Cash Flow | 125.50M | 168.42M | 73.48M | 124.97M | 76.27M | 119.43M |
| Investing Cash Flow | -59.64M | -119.77M | -98.81M | -62.37M | -18.61M | -20.69M |
| Financing Cash Flow | -17.68M | 27.34M | 26.39M | -45.37M | -67.84M | -101.16M |
Vincent Medical Holdings Limited Technical Analysis
Negative
0.83
Price Trends
0.69
Negative
0.74
Negative
0.80
Negative
Market Momentum
>-0.01
Negative
47.16
Neutral
37.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1612, the sentiment is Negative. The current price of 0.83 is above the 20-day moving average (MA) of 0.67, above the 50-day MA of 0.69, and above the 200-day MA of 0.80, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.16 is Neutral, neither overbought nor oversold. The STOCH value of 37.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1612.
Vincent Medical Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$5.44B | 12.42 | 13.24% | 2.39% | 16.15% | 31.89% | |
72 Outperform | HK$1.81B | -30.85 | -3.50% | ― | 20.65% | 127.07% | |
70 Outperform | HK$5.46B | 19.04 | 9.20% | 5.11% | 10.27% | 79.65% | |
67 Neutral | HK$442.27M | 4.51 | 13.95% | 6.87% | 10.95% | 9.26% | |
67 Neutral | HK$4.71B | 21.49 | 10.38% | 1.74% | 3.83% | -27.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$3.28B | -19.36 | -7.65% | ― | 21.23% | 36.89% |
* Healthcare Sector Average
HK:1612
Vincent Medical Holdings Limited
0.67
-0.33
-32.87%
HK:9996
Peijia Medical Ltd.
4.78
-2.52
-34.52%
HK:6669
Acotec Scientific Holdings Limited
5.76
-8.63
-59.97%
HK:1789
AK Medical Holdings Ltd.
4.94
-0.71
-12.64%
HK:1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
7.87
-7.33
-48.25%
HK:2172
MicroPort NeuroTech Limited
8.06
-5.22
-39.31%
Vincent Medical Holdings Limited Corporate Events
Vincent Medical Sets August Board Meeting to Approve Interim Results and Dividend
Aug 11, 2026
Vincent Medical Holdings Limited has scheduled a board meeting for 25 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider the publication of these interim results and evaluate t...
Vincent Medical Shareholders Approve All AGM Resolutions and Governance Updates
May 20, 2026
Vincent Medical Holdings Limited reported that all resolutions at its annual general meeting on 20 May 2026 were approved by shareholders, including adoption of the 2025 audited financial statements and a final dividend of HK2.6 cents per share. S...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.